BMO cuts UiPath stock price target on AI monetization concerns By Investing.com

UiPath reported Q4 revenue of $1.61B (+12.65% YoY) with an 83% gross margin and issued FY27 ARR growth guidance of ~10.8% (implying $200M net new ARR vs $187M in FY26). BMO cut its price target to $14 from $17 but kept a Market Perform rating; BofA and Evercore also lowered targets to $12 and $13, citing peer multiple compression and AI monetization uncertainty. The quarter beat consensus on most metrics but weaker billings trends and the need for sustained AI monetization evidence leave the outlook cautious; UiPath announced an expanded AI-powered ERP automation alliance with Deloitte.

Analysis

UiPath sits at an inflection where product-led AI value must convert into recurring, contractually backed revenue growth to sustain multiples. The next 2–4 quarters are effectively a revenue-quality exam: durable ARR growth and improving billings cadence (not just front-loaded project wins) will be required to unwind the current discount investors apply to automation plays.

Second-order beneficiaries if UiPath’s AI ERP push gains traction include ERP incumbents and cloud infra providers — increased orchestration of business workflows tends to lift consumption of managed cloud services and demand for low-latency infrastructure. Conversely, lower-tier BPO and manual services vendors face margin and volume compression as automation replaces routine FTE work, putting pressure on contracting models and services revenue over 6–24 months.

Key risks center on monetization cadence and enterprise adoption cycles: a failure to convert AI features into contracted ARR or persistent softness in billings would likely trigger another round of multiple compression within 3–6 months. A positive catalyst pathway is visible but binary — consistent sequential conversion metrics (higher sticky ARR contribution and expanding gross retention) over 3–4 quarters would re-rate the stock materially.

From a strategic viewpoint, treat current pricing as a binary-option on execution rather than secular AI adoption; short-term volatility should be managed with time-limited, asymmetric option structures or relative-value pairs that hedge product-risk against infrastructure beneficiaries.

Key Decisions for Investors

• Buy a 9–15 month PATH call spread (long-dated call, sell higher strike) to capture a re-rate if UiPath demonstrates sequential, contract-backed AI ARR growth over the next 2–4 quarters; risk limited to premium, upside 2–4x if a durable monetization narrative takes hold.
• Pair trade: long SMCI (hardware/infra exposure) vs short PATH for 6–12 months — SMCI benefits from incremental AI infra spend while PATH is exposed to execution risk on monetization; target asymmetric payoff of ~2:1 upside over downside if enterprise spend bifurcates.
• Event-driven short: establish a tactical short in PATH ahead of the next billings/earnings print with a tight 15–20% stop-loss, scaling into weakness if billings trends deteriorate; time horizon 1–3 months, take profits on a 25–40% move down.
• If seeking lower volatility exposure to the automation/AI theme, overweight software/infra providers with proven consumption economics (e.g., cloud vendors and server OEMs) rather than pure-play RPA names; horizon 6–18 months, aim for 1.5–2.5x risk/reward relative to single-stock PATH exposure.